Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page
- CheckyesterdayChange DetectedA new 'Locations' section appears with Maryland listed, and the page footer shows Revision: v3.3.3. The 'HHS Vulnerability Disclosure' link and the 'Maryland Locations' entry were removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page removed the notice about potential delays due to government funding and operating status updates. No core study content or user actions are affected, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedVisual redesign of the study details page is evident, while the underlying study data (eligibility criteria, primary and secondary outcomes, and study status) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference6%

- Check87 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.